CROMA-PHARMA®, a global leader in minimally-invasive aesthetic medicine, is excited to announce that its range of injectable polynucleotides “PhilArt” is rebranding to better reflect the products’ exceptional attributes and to position them

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

Existing Users Log In
   
New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field